Informace o publikaci

FoxO1-GAB1 axis regulates homing capacity and tonic AKT activity in chronic lymphocytic leukemia

Logo poskytovatele
Autoři

ŠEDA Václav VOJÁČKOVÁ Eva ONDRIŠOVÁ Laura KOŠŤÁLOVÁ Lenka SHARMA Sonali LOJA Tomáš MLADONICKÁ PAVLASOVÁ Gabriela ZICHA Daniel KUDLIČKOVÁ PEŠKOVÁ Marie KŘIVÁNEK Jan MATULOVÁ Květoslava KŘEN Leoš BENES V. LITZMANOVÁ Markéta BORSKÝ Marek OPPELT Jan VERNER Jan POSPÍŠILOVÁ Šárka BRYCHTOVÁ Yvona PANOVSKÁ Anna TAN Z. ZHANG S.X. DOUBEK Michael AMRUZ ČERNÁ Kateřina MAYER Jiří MRÁZ Marek

Rok publikování 2021
Druh Článek v odborném periodiku
Časopis / Zdroj Blood
Fakulta / Pracoviště MU

Středoevropský technologický institut

Citace
www https://ashpublications.org/blood/article/138/9/758/475649/FoxO1-GAB1-axis-regulates-homing-capacity-and
Doi http://dx.doi.org/10.1182/blood.2020008101
Klíčová slova DOCKING PROTEIN GAB1B-CELLSBONE-MARROWCHEMOKINE RECEPTORL-SELECTINP110-GAMMA ISOFORMEPIDERMAL-GROWTHTYROSINE KINASEPI3 KINASEIBRUTINIB
Popis Recirculation of chronic lymphocytic leukemia (CLL) cells between the peripheral blood and lymphoid niches plays a critical role in disease pathophysiology, and inhibiting this process is one of the major mechanisms of action for B-cell receptor (BCR) inhibitors such as ibrutinib and idelalisib. Migration is a complex process guided by chemokine receptors and integrins. However, it remains largely unknown how CLL cells integrate multiple migratory signals while balancing survival in the peripheral blood and the decision to return to immune niches. Our study provided evidence that CXCR4/CD5 intraclonal subpopulations can be used to study the regulation of migration of CLL cells. We performed RNA profiling of CXCR4(dim)CD5(bright) vs CXCR4(bright) CD5(dim) CLL cells and identified differential expression of dozens of molecules with a putative function in cell migration. GRB2-associated binding protein 1 (GAB1) positively regulated CLL cell homing capacity of CXCR4(bright)DD5(dim) cells. Gradual GAB1 accumulation in CLL cells outside immune niches was mediated by FoxO1-induced transcriptional GAB1 activation. Upregulation of GAB1 also played an important role in maintaining basal phosphatidylinositol 3-kinase (P13K) activity and the "tonic" AKT phosphorylation required to sustain the survival of resting CLL B cells. This finding is important during ibrutinib therapy, because CLL cells induce the FoxO1-GAB1-pAKT axis, which represents an adaptation mechanism to the inability to home to immune niches. We have demonstrated that GAB1 can be targeted therapeutically by novel GAB1 inhibitors, alone or in combination with BTK inhibition. GAB1 inhibitors induce CLL cell apoptosis, impair cell migration, inhibit tonic or BCR-induced AKT phosphorylation, and block compensatory AKT activity during ibrutinib therapy.
Související projekty:

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.

Další info